title: Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
abstract: Sarcolemmal ATP-sensitive potassium channels (K(ATP)) act as metabolic sensors that facilitate adaptation of the left ventricle to changes in energy requirements. This study examined the mechanism by which K(ATP) dysfunction impairs the left ventricular response to stress using transgenic mouse strains with cardiac-specific disruption of K(ATP) activity (SUR1-tg mice) or Kir6.2 gene deficiency (Kir6.2 KO). Both SUR1-tg and Kir6.2 KO mice had normal left ventricular mass and function under unstressed conditions. Following chronic transverse aortic constriction, both SUR1-tg and Kir6.2 KO mice developed more severe left ventricular hypertrophy and dysfunction as compared with their corresponding WT controls. Both SUR1-tg and Kir6.2 KO mice had significantly decreased expression of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha and a group of energy metabolism related genes at both protein and mRNA levels. Furthermore, disruption of K(ATP) repressed expression and promoter activity of PGC-1alpha in cultured rat neonatal cardiac myocytes in response to hypoxia, indicating that K(ATP) activity is required to maintain PGC-1alpha expression under stress conditions. PGC-1alpha gene deficiency also exacerbated chronic transverse aortic constriction-induced ventricular hypertrophy and dysfunction, suggesting that depletion of PGC-1alpha can worsen systolic overload induced ventricular dysfunction. Both SUR1-tg and Kir6.2 KO mice had decreased FOXO1 after transverse aortic constriction, in agreement with the reports that a decrease of FOXO1 can repress PGC-1alpha expression. Furthermore, inhibition of K(ATP) caused a decrease of FOXO1 associated with PGC-1alpha promoter. These data indicate that K(ATP) channels facilitate the cardiac response to stress by regulating PGC-1alpha and its target genes, at least partially through the FOXO1 pathway.
authors.affiliation: Cardiovascular Division, Department of Medicine, Universityof Minnesota Medical School, Minneapolis, MN 55455, USA.
authors.forename: Xinli
authors.initials: X
authors.lastname: Hu
authors.forename: Xin
authors.initials: X
authors.lastname: Xu
authors.forename: Yimin
authors.initials: Y
authors.lastname: Huang
authors.forename: John
authors.initials: J
authors.lastname: Fassett
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Flagg
authors.forename: Ying
authors.initials: Y
authors.lastname: Zhang
authors.forename: Colin G
authors.initials: CG
authors.lastname: Nichols
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Bache
authors.forename: Yingjie
authors.initials: Y
authors.lastname: Chen
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D001011:Aorta / Q000601:surgery; D001483:Base Sequence; D015687:Cell Hypoxia; D002478:Cells, Cultured; D003250:Constriction; D004195:Disease Models, Animal; D004734:Energy Metabolism / Q000235:genetics; D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors / Q000378:metabolism; D006439:Hemodynamics; D017379:Hypertrophy, Left Ventricular / Q000378:metabolism* / Q000503:physiopathology; D054086:KATP Channels / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D009154:Mutation; D009206:Myocardium / Q000378:metabolism*; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024661:Potassium Channels, Inwardly Rectifying / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D034622:RNA Interference; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism*; D012720:Severity of Illness Index; D064233:Sulfonylurea Receptors; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors; D014162:Transfection; D018487:Ventricular Dysfunction, Left / Q000378:metabolism* / Q000503:physiopathology; D000099161:Kcnj11 Channel
chemical_list: D018528:ATP-Binding Cassette Transporters; D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors; D054086:KATP Channels; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D026902:Potassium Channel Blockers; D024661:Potassium Channels, Inwardly Rectifying; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D011955:Receptors, Drug; D064233:Sulfonylurea Receptors; D015534:Trans-Activators; D014157:Transcription Factors; D000099161:Kcnj11 Channel; C577508:Abcc8 protein, mouse; C577509:Abcc8 protein, rat; C467200:Foxo1 protein, mouse; C485290:Ppargc1a protein, mouse
references.citation: J Clin Invest. 2002 Feb;109(4):509-16
references.pmid: 11854323
references.citation: Physiol Genomics. 2006 Oct 11;27(2):156-70
references.pmid: 16882883
references.citation: J Biol Chem. 2002 Jun 21;277(25):22528-33
references.pmid: 11956204
references.citation: J Clin Invest. 2002 Jul;110(2):203-8
references.pmid: 12122112
references.citation: J Mol Cell Cardiol. 2006 Dec;41(6):998-1009
references.pmid: 17064727
references.citation: J Physiol. 2006 Dec 15;577(Pt 3):1053-65
references.pmid: 17038430
references.citation: Cardiovasc Res. 2007 Jan 15;73(2):269-77
references.pmid: 17010956
references.citation: Nature. 2007 Mar 22;446(7134):444-8
references.pmid: 17334357
references.citation: Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1706-13
references.pmid: 17189350
references.citation: Circ Res. 2007 Apr 13;100(7):1089-98
references.pmid: 17363700
references.citation: Cell Metab. 2007 Jul;6(1):13-24
references.pmid: 17618853
references.citation: Cell Metab. 2007 Jul;6(1):25-37
references.pmid: 17618854
references.citation: J Mol Cell Cardiol. 2006 Nov;41(5):893-901
references.pmid: 16962131
references.citation: Hypertension. 2008 Jun;51(6):1557-64
references.pmid: 18391093
references.citation: J Clin Invest. 2000 Oct;106(7):847-56
references.pmid: 11018072
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13278-83
references.pmid: 12271142
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1711-6
references.pmid: 12578979
references.citation: Diabetes. 2003 Mar;52(3):642-9
references.pmid: 12606503
references.citation: Nat Genet. 2004 Apr;36(4):382-7
references.pmid: 15034580
references.citation: J Biol Chem. 2004 Sep 10;279(37):38903-11
references.pmid: 15247222
references.citation: J Neurol Sci. 1992 Mar;108(1):105-13
references.pmid: 1320661
references.citation: J Biol Chem. 1998 May 15;273(20):12593-8
references.pmid: 9575220
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10402-6
references.pmid: 9724715
references.citation: Nature. 1998 Dec 10;396(6711):584-7
references.pmid: 9859994
references.citation: Nat Genet. 1999 Jan;21(1):133-7
references.pmid: 9916807
references.citation: Cell. 1999 Mar 19;96(6):857-68
references.pmid: 10102273
references.citation: Diabetes. 2004 Dec;53 Suppl 3:S169-75
references.pmid: 15561907
references.citation: PLoS Biol. 2005 Apr;3(4):e101
references.pmid: 15760270
references.citation: J Mol Cell Cardiol. 2005 Jun;38(6):917-25
references.pmid: 15910876
references.citation: Cell Metab. 2005 Apr;1(4):259-71
references.pmid: 16054070
references.citation: J Clin Invest. 2005 Aug;115(8):2108-18
references.pmid: 16075055
references.citation: J Mol Cell Cardiol. 2005 Oct;39(4):647-56
references.pmid: 16099470
references.citation: FASEB J. 2005 Dec;19(14):2072-4
references.pmid: 16203862
references.citation: J Biol Chem. 2006 Jan 13;281(2):1091-8
references.pmid: 16282329
references.citation: J Clin Invest. 2006 Mar;116(3):615-22
references.pmid: 16511594
references.citation: Physiol Genomics. 2006 Mar 13;25(1):105-15
references.pmid: 16403845
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10086-91
references.pmid: 16775082
references.citation: Hum Mol Genet. 2006 Aug 1;15(15):2285-97
references.pmid: 16782803
references.citation: Diabetologia. 2006 Oct;49(10):2368-78
references.pmid: 16924481
references.citation: Clin Exp Pharmacol Physiol. 2002 Apr;29(4):339-45
references.pmid: 11985547